LEXICON PHARMACEUTICALS, INC. - LXRX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 03, 2026 | Chief Executive Officer | M | D | 503,263.0 | — | — | 1,006,527.0 | View | |
| Mar 03, 2026 | Chief Executive Officer | F | D | 204,831.0 | 1.47 | 301,101.57 | 298,432.0 | View | |
| Mar 03, 2026 | Chief Executive Officer | M | A | 503,263.0 | — | — | 503,263.0 | View | |
| Mar 03, 2026 | SVP, Chief Financial Officer | M | D | 160,237.0 | — | — | 320,473.0 | View | |
| Mar 03, 2026 | SVP, Chief Financial Officer | F | D | 54,881.0 | 1.47 | 80,675.07 | 105,356.0 | View | |
| Mar 03, 2026 | SVP, Chief Financial Officer | M | A | 160,237.0 | — | — | 160,237.0 | View | |
| Mar 03, 2026 | SVP, General Counsel & Secr. | M | D | 170,163.0 | — | — | 340,327.0 | View | |
| Mar 03, 2026 | SVP, General Counsel & Secr. | M | D | 33,457.0 | — | — | 0.0 | View | |
| Mar 03, 2026 | SVP, General Counsel & Secr. | M | D | 69,386.0 | — | — | 69,387.0 | View | |
| Mar 03, 2026 | SVP, General Counsel & Secr. | F | D | 105,019.0 | 1.47 | 154,377.93 | 428,802.0 | View | |
| Mar 03, 2026 | SVP, General Counsel & Secr. | M | A | 170,163.0 | — | — | 533,821.0 | View | |
| Mar 03, 2026 | SVP, General Counsel & Secr. | M | A | 69,386.0 | — | — | 330,201.0 | View | |
| Mar 03, 2026 | SVP, General Counsel & Secr. | M | A | 33,457.0 | — | — | 363,658.0 | View | |
| Mar 03, 2026 | SVP, IR and Corp Comm | M | D | 128,190.0 | — | — | 256,380.0 | View | |
| Mar 03, 2026 | SVP, IR and Corp Comm | M | D | 24,674.0 | — | — | 24,673.0 | View | |
| Mar 03, 2026 | SVP, IR and Corp Comm | F | D | 74,572.0 | 1.47 | 109,620.84 | 93,869.0 | View | |
| Mar 03, 2026 | SVP, IR and Corp Comm | M | A | 128,190.0 | — | — | 168,441.0 | View | |
| Mar 03, 2026 | SVP, IR and Corp Comm | M | A | 24,674.0 | — | — | 40,251.0 | View | |
| Mar 03, 2026 | SVP, Discovery | M | D | 65,640.0 | — | — | 131,280.0 | View | |
| Mar 03, 2026 | SVP, Discovery | M | D | 20,310.0 | — | — | 20,310.0 | View | |
| Mar 03, 2026 | SVP, Discovery | M | D | 14,000.0 | — | — | 0.0 | View | |
| Mar 03, 2026 | SVP, Discovery | F | D | 24,338.0 | 1.47 | 35,776.86 | 150,132.0 | View | |
| Mar 03, 2026 | SVP, Discovery | M | A | 65,640.0 | — | — | 174,470.0 | View | |
| Mar 03, 2026 | SVP, Discovery | M | A | 20,310.0 | — | — | 108,830.0 | View | |
| Mar 03, 2026 | SVP, Discovery | M | A | 14,000.0 | — | — | 88,520.0 | View | |
| Mar 03, 2026 | SVP, Chief Medical Officer | M | D | 202,260.0 | — | — | 404,520.0 | View | |
| Mar 03, 2026 | SVP, Chief Medical Officer | M | D | 74,226.0 | — | — | 74,227.0 | View | |
| Mar 03, 2026 | SVP, Chief Medical Officer | M | D | 35,790.0 | — | — | 0.0 | View | |
| Mar 03, 2026 | SVP, Chief Medical Officer | F | D | 109,098.0 | 1.47 | 160,374.06 | 323,430.0 | View | |
| Mar 03, 2026 | SVP, Chief Medical Officer | M | A | 202,260.0 | — | — | 432,528.0 | View | |
| Mar 03, 2026 | SVP, Chief Medical Officer | M | A | 74,226.0 | — | — | 230,268.0 | View | |
| Mar 03, 2026 | SVP, Chief Medical Officer | M | A | 35,790.0 | — | — | 156,042.0 | View | |
| Mar 03, 2026 | SVP, Partnerships & Corp Strat | M | D | 67,090.0 | — | — | 134,180.0 | View | |
| Mar 03, 2026 | SVP, Partnerships & Corp Strat | F | D | 35,826.0 | 1.47 | 52,664.22 | 31,264.0 | View | |
| Mar 03, 2026 | SVP, Partnerships & Corp Strat | M | A | 67,090.0 | — | — | 67,090.0 | View | |
| Mar 03, 2026 | SVP, Human Resources | M | D | 144,393.0 | — | — | 288,787.0 | View | |
| Mar 03, 2026 | SVP, Human Resources | M | D | 52,316.0 | — | — | 52,317.0 | View | |
| Mar 03, 2026 | SVP, Human Resources | M | D | 27,697.0 | — | — | 0.0 | View | |
| Mar 03, 2026 | SVP, Human Resources | F | D | 68,107.0 | 1.47 | 100,117.29 | 277,945.0 | View | |
| Mar 03, 2026 | SVP, Human Resources | M | A | 144,393.0 | — | — | 346,052.0 | View | |
| Mar 03, 2026 | SVP, Human Resources | M | A | 52,316.0 | — | — | 201,659.0 | View | |
| Mar 03, 2026 | SVP, Human Resources | M | A | 27,697.0 | — | — | 149,343.0 | View | |
| Feb 27, 2026 | — | P | A | 2,000.0 | 1.49 | 2,980.0 | 1,906,186.0 | View | |
| Feb 25, 2026 | — | P | A | 100,000.0 | 1.47 | 147,000.0 | 1,904,186.0 | View | |
| Feb 23, 2026 | — | P | A | 100,000.0 | 1.4779 | 147,790.0 | 1,804,186.0 | View | |
| Feb 23, 2026 | — | P | A | 50,000.0 | 1.4393 | 71,965.0 | 1,704,186.0 | View | |
| Feb 19, 2026 | — | A | A | 41,289.58 | 65.0 | 2,683,822.7 | 408,434.7 | View | |
| Feb 18, 2026 | — | P | A | 133,688.0 | 1.32 | 176,468.16 | 1,654,186.0 | View | |
| Feb 18, 2026 | — | P | A | 76,857.0 | 1.3082 | 100,544.33 | 1,520,498.0 | View | |
| Feb 18, 2026 | — | P | A | 57,952.0 | 1.3093 | 75,876.55 | 1,443,641.0 | View | |
| Feb 17, 2026 | Chief Executive Officer | A | A | 1,293,670.0 | 0.0 | 0.0 | 1,293,670.0 | View | |
| Feb 17, 2026 | Chief Executive Officer | A | A | 862,440.0 | 0.0 | 0.0 | 862,440.0 | View | |
| Feb 17, 2026 | SVP, Chief Financial Officer | A | A | 409,020.0 | 0.0 | 0.0 | 409,020.0 | View | |
| Feb 17, 2026 | SVP, Chief Financial Officer | A | A | 272,680.0 | 0.0 | 0.0 | 272,680.0 | View | |
| Feb 17, 2026 | SVP, General Counsel & Secr. | A | A | 449,560.0 | 0.0 | 0.0 | 449,560.0 | View | |
| Feb 17, 2026 | SVP, General Counsel & Secr. | A | A | 299,710.0 | 0.0 | 0.0 | 299,710.0 | View | |
| Feb 17, 2026 | SVP, IR and Corp Comm | A | A | 386,300.0 | 0.0 | 0.0 | 386,300.0 | View | |
| Feb 17, 2026 | SVP, IR and Corp Comm | A | A | 257,530.0 | 0.0 | 0.0 | 257,530.0 | View | |
| Feb 17, 2026 | SVP, Discovery | A | A | 357,680.0 | 0.0 | 0.0 | 357,680.0 | View | |
| Feb 17, 2026 | SVP, Discovery | A | A | 238,450.0 | 0.0 | 0.0 | 238,450.0 | View | |
| Feb 17, 2026 | SVP, Chief Medical Officer | A | A | 519,920.0 | 0.0 | 0.0 | 519,920.0 | View | |
| Feb 17, 2026 | SVP, Chief Medical Officer | A | A | 346,610.0 | 0.0 | 0.0 | 346,610.0 | View | |
| Feb 17, 2026 | SVP, Partnerships & Corp Strat | A | A | 290,620.0 | 0.0 | 0.0 | 290,620.0 | View | |
| Feb 17, 2026 | SVP, Partnerships & Corp Strat | A | A | 193,740.0 | 0.0 | 0.0 | 193,740.0 | View | |
| Feb 17, 2026 | SVP, Human Resources | A | A | 375,300.0 | 0.0 | 0.0 | 375,300.0 | View | |
| Feb 17, 2026 | SVP, Human Resources | A | A | 250,200.0 | 0.0 | 0.0 | 250,200.0 | View | |
| Feb 04, 2026 | — | A | A | 367,145.12 | 65.0 | 23,864,432.8 | 367,145.12 | View | |
| Feb 04, 2026 | — | P | A | 1,538,462.0 | 1.3 | 2,000,000.6 | 1,538,462.0 | View | |
| Feb 04, 2026 | — | A | A | 3,846,154.0 | 1.3 | 5,000,000.2 | 7,362,368.0 | View | |
| Feb 04, 2026 | — | A | A | 18,553,846.0 | 1.3 | 24,119,999.8 | 154,734,327.0 | View |